We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+14.44%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
AUM
$748M
AUM Growth
+$54.9M
Cap. Flow
-$10.4M
Cap. Flow %
-1.39%
Top 10 Hldgs %
68.09%
Holding
35
New
8
Increased
7
Reduced
6
Closed
12

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$64.2M
2
UNH icon
UnitedHealth
UNH
+$37.8M
3
GILD icon
Gilead Sciences
GILD
+$34.8M
4
EVH icon
Evolent Health
EVH
+$32.5M
5
CRL icon
Charles River Laboratories
CRL
+$26.2M

Sector Composition

Rank Sector Weight
1 Healthcare 97.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$162B
-420,000
Closed -$34.8M
IDXX icon
27
Idexx Laboratories
IDXX
$43.9B
-50,000
Closed -$25M
LEGN icon
28
Legend Biotech
LEGN
$3.73B
-500,000
Closed -$24.1M
SDGR icon
29
Schrodinger
SDGR
$1.14B
-595,697
Closed -$15.7M
SNY icon
30
Sanofi
SNY
$105B
-1,179,736
Closed -$64.2M
SRPT icon
31
Sarepta Therapeutics
SRPT
$1.68B
-160,000
Closed -$22.1M
STXS icon
32
Stereotaxis
STXS
$130M
-1,832,577
Closed -$3.74M
TSVT
33
DELISTED
2seventy bio
TSVT
-868,939
Closed -$8.86M
UNH icon
34
UnitedHealth
UNH
$379B
-80,000
Closed -$37.8M
CUTR
35
DELISTED
Cutera, Inc.
CUTR
-600,000
Closed -$14.2M

Similar funds

Iron Triangle Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Iron Triangle Partners held 35 positions worth $748M, up 7.9% from $693M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Iron Triangle Partners's Q2 2023 filing shows 8 new, 7 increased, 6 reduced and 12 closed positions. Its largest new stake was Universal Health Services: 470,000 shares worth $74.2M. The largest sale was Sanofi, an estimated $64.2M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 100% a quarter earlier.

  • Iron Triangle Partners's largest Q2 2023 buy was Universal Health Services: 470,000 shares worth $74.2M.
  • Iron Triangle Partners added most to Icon in Q2 2023, an estimated $34M increase.
  • Iron Triangle Partners's biggest Q2 2023 reduction was DexCom, cutting an estimated $23M.
  • Iron Triangle Partners fully exited Sanofi in Q2 2023, selling an estimated $64.2M.
  • Iron Triangle Partners's ten largest holdings make up 68% of its $748M portfolio in Q2 2023.
  • Iron Triangle Partners opened 8 new positions and closed 12 in Q2 2023.
  • Iron Triangle Partners's portfolio value rose 7.9% quarter-over-quarter to $748M.

Based on Iron Triangle Partners's 13F filing for Q2 2023, filed 14 Aug 2023.